Discover
MRVI
Maravai LifeSciences Holdings, Inc.
7.44
2 x 5.32
2 x 9.25
bid
ask
+
0.23
3.19%
2 @ 07:57 PM
7.52 +0.08 (1.08%)
| Ytd | 128.92% | |
| 1y | 125.45% |
7.17
day range
7.52
2.83
52 week range
9.00
| Open | 7.23 | Prev Close | 7.21 | Low | 7.17 | High | 7.52 | Mkt Cap | 2.76B |
| Vol | 2.31M | Avg Vol | 3.36M | EPS | -0.55 | P/E | N/A | Forward P/E | -73.91 |
| Beta | 0.54 | Short Ratio | 2.58 | Inst. Own | 99.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 7.16 | 200-d Avg | 4.93 | 1yr Est | 7.83 |
| Income Statement | |||
| Total Revenue | 51.44M | ||
| Revenues (USD) | 51.44M | ||
| Cost of Revenue | 30.79M | ||
| Gross Profit | 20.65M | ||
| Operating Expenses | 35.74M | ||
| Research and Development Expense | 3.70M | ||
| Selling, General and Administrative Expense | 32.07M | ||
| Operating Income | -15.09M | ||
| Interest Expense | 4.81M | ||
| Income Tax Expense | -171.00K | ||
| Net Income | -12.42M | ||
| Net Income Common Stock | -12.42M | ||
| Net Income Common Stock (USD) | -12.42M | ||
| Consolidated Income | -21.63M | ||
| Net Income to Non-Controlling Interests | -9.21M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -7.78M | ||
| Earning Before Interest & Taxes (USD) | -7.78M | ||
| Weighted Average Shares | 148.00M | ||
| Weighted Average Shares Diluted | 148.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 70.09M | ||
| Cash and Equivalents (USD) | 70.09M | ||
| Trade and Non-Trade Receivables | 31.14M | ||
| Current Assets | 155.66M | ||
| Property, Plant & Equipment Net | 142.41M | ||
| Total Assets | 603.75M | ||
| Debt Current | 1.13M | ||
| Total Debt | 176.70M | ||
| Current Liabilities | 38.42M | ||
| Debt Non-Current | 175.57M | ||
| Total Liabilities | 248.16M | ||
| Accumulated Retained Earnings (Deficit) | -6.03M | ||
| Accumulated Other Comprehensive Income | 459.00K | ||
| Shareholders Equity | 204.62M | ||
| Shareholders Equity (USD) | 204.62M | ||
| Assets Non-Current | 448.09M | ||
| Total Debt (USD) | 176.70M | ||
| Goodwill and Intangible Assets | 267.80M | ||
| Inventory | 41.23M | ||
| Liabilities Non-Current | 209.74M | ||
| Trade and Non-Trade Payables | 7.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.41M | ||
| Net Cash Flow from Financing | -98.98M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -95.34M | ||
| Capital Expenditure | -370.00K | ||
| Issuance (Repayment) of Debt Securities | -96.45M | ||
| Net Cash Flow from Investing | -370.00K | ||
| Net Cash Flow from Operations | 3.99M | ||
| Effect of Exchange Rate Changes on Cash | 17.00K | ||
| Share Based Compensation | 10.21M | ||